Leaderboards/Ovarian cancer diagnosis and treatment

Ovarian cancer diagnosis and treatment

Last updated June 1, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Alison W. Loren
University of Pennsylvania
99
2
Nathan A. Berger
Case Western Reserve University
92
3
Domenica Lorusso
Humanitas University
81
4
Tiannan Guo
Westlake University
79
5
Rajeev Kumar
National Institute of Technology Hamirpur
63
6
Xuefeng Wang
Third Affiliated Hospital of Southern Medical University
59
7
Sohrab P. Shah
Memorial Sloan Kettering Cancer Center
59
8
Felix Hilpert
Arbeitsgemeinschaft Gynäkologische Onkologie Studiengruppe
58
9
Huanjie Shao
Shaanxi Normal University
57
10
Deborah Cairns
University of Glasgow
56

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Giuseppe Caruso
Mayo Clinic
99
2
Alexander Olawaiye
Magee-Womens Hospital
92
3
Marc Williams
Memorial Sloan Kettering Cancer Center
71
4
Jeah Jung
George Mason University
66
5
Claudia Allemani
London School of Hygiene & Tropical Medicine
64
6
Gabriel Pasquarelli-do-Nascimento
Universidade de Brasília
61
7
Reihaneh Safavi‐Sohi
Seton Hall University
61
8
Stacey DaCosta Byfield
Optum (United States)
58
9
Xing-Ming Chen
Kunming Medical University
58
10
Luis Chiva
Clinica Universidad de Navarra
56

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Elżbieta Senkus
Gdańsk Medical University
99
2
Michel P. Coleman
London School of Hygiene & Tropical Medicine
97
3
John B. Wong
Tufts University
85
4
Leslie L. Robison
Unknown
80
5
James D. Brenton
University of Cambridge
80
6
Freddie Bray
Centre international de recherche sur le cancer
79
7
E.P. Winer
Dana-Farber Cancer Institute
77
8
Paul L. Nguyen
Beth Israel Deaconess Medical Center
73
9
Fátima Cardoso
Champalimaud Foundation
70
10
Susan J. Ramus
University of Southern California
65

All-Time Leaders Papers

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
22.1k cit.
2
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
Annals of Oncology|2016
2.1k cit.
3
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
New England Journal of Medicine|2016
2k cit.
4
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
The Lancet Oncology|2019
1k cit.
5
Screening for Osteoporosis to Prevent Fractures
JAMA|2018
645 cit.
6
Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: a population-based study
The Lancet Oncology|2017
583 cit.
7
Screening for Prediabetes and Type 2 Diabetes
JAMA|2021
454 cit.
8
Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis
PLoS Medicine|2015
416 cit.
9
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
The Breast|2014
332 cit.
10
Clinical and Genomic Characterization of Low–Prostate-specific Antigen, High-grade Prostate Cancer
European Urology|2018
102 cit.

Reagents for Ovarian cancer diagnosis and treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

NONO (E8Q3E) Rabbit Monoclonal Antibody

Cited in 8 papers
#10162$161
View Evidence →Cell Signaling Technology

Phospho-p40phox (Thr154) Antibody

Cited in 7 papers
#4311$362
View Evidence →Cell Signaling Technology

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

Cited in 7 papers
#94805$465
View Evidence →

🌟 All-Time

Most validated

Proteintech

PAX8 antibody

Cited in 28 papers
#10336-1-AP$449
View Evidence →Cell Signaling Technology

Phospho-4E-BP1 (Thr37/46) (236B4) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 9 papers
#7547$493
View Evidence →Proteintech

Geminin antibody

Cited in 8 papers
#10802-1-AP$449
View Evidence →